|1.||Bartsch, Rupert: 1 article (06/2015)|
|2.||Berghoff, Anna S: 1 article (06/2015)|
|3.||Rudas, Margaretha: 1 article (06/2015)|
|4.||Preusser, Matthias: 1 article (06/2015)|
|5.||Bergen, Elisabeth S: 1 article (06/2015)|
|6.||Crosato, M: 1 article (03/2002)|
|7.||Chioin, R: 1 article (03/2002)|
|8.||Calzolari, V: 1 article (03/2002)|
|9.||Calabrese, F: 1 article (03/2002)|
|10.||Boffa, G M: 1 article (03/2002)|
01/01/1987 - "The tremor response to BM-5 was bell-shaped, the peak dose being around 2 mg/kg. In contrast, the salivary response increased with increasing doses of BM-5. "
01/01/1987 - "In vivo studies in mice and rats indicated that this compound is a partial muscarinic agonist with large regional differences in its efficacy: BM-5 produced low tremor in doses which evoke full salivary response. "
01/01/1987 - "Chronic treatment of mice with BM-5 (0.2-2 mg/kg) for 14 days also showed that BM-5 at higher doses, behaved as an antagonist, since it caused supersensitivity to oxotremorine on the tremor response. "
01/01/1987 - "The maximal tremor response to BM-5 was much smaller than that produced by oxotremorine, while the maximal salivary response to BM-5 was greater than that evoked by oxotremorine. "
08/01/1987 - "Compounds such as AKS 19 and BM 5 having low intrinsic efficacy (partial agonists) differentiated between centrally mediated muscarinic effects as they, like oxotremorine, were potent in producing analgesia and hypothermia but did not produce tremor. "
01/01/1999 - "In a previous report, we showed that Anticarsia gemmatalis nucleopolyhedrovirus (AgMNPV) infections of Choristoneura fumiferana IPRI-CF-124T and Bombyx mori BM-5 cell lines are abortive, whereas A. "
01/01/1997 - "Infections of Bombyx mori BM-5 cell lines were abortive, and cells had apoptosis-like morphology. "
07/01/1993 - "Eighteen patients with malignant lymphoma, 10 non-Hodgkin's and 8 Hodgkin's, were treated with high-dose CVB (cyclophosphamide 4 x 1.5 g/m2, etoposide 4 x 250-400 mg/m2, carmustine 4 x 150-200 mg/m2), followed by autologous peripheral blood stem cells (PBSC, 13 patients) or bone marrow (BM, 5 patients) transplantation. "
04/01/1990 - "Effects of Glyteer (GL, 5%) on Type I-Type IV allergic reactions were investigated by its topical application to rats and mice, and the effects were compared with those of betamethasone 17-valerate (BV, 0.12%), indomethacin (ID, 1%), and bufexamac (BM, 5%), which were all prepared with the same ointment base. "
|4.||Etoposide (VP 16)
|8.||Betamethasone 17-Valerate (Betamethasone 17 Valerate)
|1.||Transplantation (Transplant Recipients)